Diabetes Update | US Pharmacist

July 2022

Nerve Cells Identified That May Help Curb Appetite
According to research published in Nature Metabolism, scientists from the University of Cologne in Germany reported that they have discovered an increased rate of type 2 diabetes and obesity in individuals with impaired synaptic signaling of lysophospholipids, controlled by agouti-related peptide neurons. The researchers suggested that administration of inhibitors can modulate excessive food intake. Read more.

Perioperative Hyperglycemia Excursions Worse in Nondiabetics
Perioperative hyperglycemia is an established risk factor associated with surgical complications and has in fact been traditionally associated with the diagnosis of diabetes. However, researchers have found that individuals without diabetes who experience similar hyperglycemic excursions have even a greater risk of complications when compared to their counterparts with the disease. Learn more.

Good Dental Health Translates Into Better Medical Health
Results presented on June 17, 2022, at EuroPerio10—an important periodontology and implant dentistry meeting—highlighted research that identifies severe gum disease, otherwise described as periodontitis stages III and IV, as a condition associated with glycosylated hemoglobin A1C (HbA1c) levels, diabetes, and myocardial infarction. Learn more about the HUNT Study.

Connect With U.S. Pharmacist